source
- Experts warn of safety risks as FDA targets compounded GLP-1 weight-loss drugs sold by telehealth firmsAt the HLTH conference, experts highlighted growing concerns about telehealth companies that sell compounded GLP-1 weight-loss medications. These firms create custom formulations and ship them dir…
- White House pulls nomination for FDA nominee OvertonThe sudden end of Heidi Overton’s candidacy likely ensures a Democrat-controlled Congress will choose the FDA’s next leader — but shouldn’t disrupt the agency, analysts say.BioPharma Dive · 2d ago↗ source